Trial · NCT01485172
Results by group66
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 66
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline (BL) in Unified Parkinson Disease (PD) Rating Scale (UPDRS) Motor Score | Treatment Group A: Placebo | -1.91 | 95% Confidence Interval -4.15 to 0.34 | Score on a scale | |
| Change From Baseline (BL) in Unified Parkinson Disease (PD) Rating Scale (UPDRS) Motor Score | Treatment Group B: 2 mg/Day | -1.58 | 95% Confidence Interval -5.02 to 1.86 | Score on a scale | |
| Change From Baseline (BL) in Unified Parkinson Disease (PD) Rating Scale (UPDRS) Motor Score | Treatment Group C: 4 mg/Day | -2.76 | 95% Confidence Interval -5.04 to -0.49 | Score on a scale | |
| Change From Baseline (BL) in Unified Parkinson Disease (PD) Rating Scale (UPDRS) Motor Score | Treatment Group D: 8 mg/Day | -4.31 | 95% Confidence Interval -6.48 to -2.15 | Score on a scale | |
| Change From Baseline (BL) in Unified Parkinson Disease (PD) Rating Scale (UPDRS) Motor Score | Treatment Group E: 12 mg/Day | -4.07 | 95% Confidence Interval -6.32 to -1.82 | Score on a scale | |
| Change From Baseline (BL) in Unified Parkinson Disease (PD) Rating Scale (UPDRS) Motor Score | Treatment Group F: 24 mg/Day | -2.83 | 95% Confidence Interval -6.61 to 0.95 | Score on a scale | |
| Number of Participants With a >=5 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group A: Placebo | 9 | Participants | ||
| Number of Participants With a >=5 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group B: 2 mg/Day | 6 | Participants | ||
| Number of Participants With a >=5 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group C: 4 mg/Day | 14 | Participants | ||
| Number of Participants With a >=5 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group D: 8 mg/Day | 16 | Participants | ||
| Number of Participants With a >=5 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group E: 12 mg/Day | 19 | Participants | ||
| Number of Participants With a >=5 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group F: 24 mg/Day | 5 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group A: Placebo | 5 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group B: 2 mg/Day | 3 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group C: 4 mg/Day | 7 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group D: 8 mg/Day | 7 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group E: 12 mg/Day | 9 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Motor Score | Treatment Group F: 24 mg/Day | 2 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Parts II and III Combined | Treatment Group A: Placebo | 6 | Participants | ||
| Number of Participants With a >=10 Points Reduction From Baseline in UPDRS Parts II and III Combined | Treatment Group B: 2 mg/Day | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01485172/results